FDA approves Cyberonics Aspire High Capacity generator for vagus nerve stimulation therapy
Links shared publicly online about this topic.
- 536total visits
FDA approves Cyberonics Aspire High Capacity generator for vagus nerve stimulation therapy
Cyberonics, Inc. today announced that the AspireHC™ (High Capacity) generator for use in vagus nerve stimulation (VNS) therapy was approved by the United States Food and Drug Administration (FDA) for commercial release.
View full resource at news-medical.net
Tags: Seizure, Epilepsy, Diet and Nutrition, Drug, FDA, News
Most Recently Shared on February 2, 2011 at 12:47 pm By:
Epilepsy News: FDA approves Cyberonics Aspire High Capacity generator for vagus nerve stimulation therapy: Cyber... http://bit.ly/hWqUP4
Advertisement
